Detalles de la búsqueda
1.
2-Step-Scores with optional nephropathology for the prediction of adverse outcomes for brain-dead donor kidneys in Eurotransplant.
Nephrol Dial Transplant
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632055
2.
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
Kidney Int
; 104(3): 552-561, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343659
3.
Should kidney allografts from old donors be allocated only to old recipients?
Transpl Int
; 33(8): 849-857, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32337766
4.
Repeated kidney re-transplantation-the Eurotransplant experience: a retrospective multicenter outcome analysis.
Transpl Int
; 33(6): 617-631, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903658
5.
Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.
Am J Transplant
; 18(12): 2965-2976, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722128
6.
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
BMC Nephrol
; 19(1): 237, 2018 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231851
7.
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.
BMC Nephrol
; 19(1): 154, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29954336
8.
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
Nephrol Dial Transplant
; 32(6): 1060-1070, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28605781
9.
Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.
Nephrol Dial Transplant
; 32(5): 880-889, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28340245
10.
Rescue allocation and recipient oriented extended allocation in kidney transplantation-influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially nonaccepted organs.
Transpl Int
; 30(12): 1226-1233, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28574620
11.
Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease.
Nephrol Dial Transplant
; 31(2): 284-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25832108
12.
High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey.
Nephrol Dial Transplant
; 31(9): 1515-22, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26908765
13.
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial.
Clin Nephrol
; 85(4): 215-25, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26932178
14.
Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study.
Clin Nephrol
; 83(1): 11-21, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512099
15.
Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database.
Clin Transplant
; 28(1): 67-79, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372584
16.
Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
Transpl Int
; 27(1): 60-8, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24131087
17.
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.
Transpl Int
; 27(1): 77-86, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24164420
18.
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study.
Transpl Int
; 27(11): 1192-204, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25070687
19.
Everolimus in patients with autosomal dominant polycystic kidney disease.
N Engl J Med
; 363(9): 830-40, 2010 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20581392
20.
A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year.
Clin Nephrol
; 79(6): 421-31, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23611518